Eden Research (LON:EDEN) Stock Price Down 13.2% – What’s Next?

Posted by Micah Haroldson on Apr 2nd, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s share price traded down 13.2% during mid-day trading on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares traded hands during mid-day trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Price Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a 50-day simple moving average of GBX 3.36 and a 200 day simple moving average of GBX 3.71. The stock has a market capitalization of £14.35 million, a price-to-earnings ratio of -9.42 and a beta of 0.92.

Insider Transactions at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,238.53). Also, insider Sean M. Smith acquired 426,986 shares of the business’s stock in a transaction that occurred on Tuesday, April 1st. The shares were acquired at an average cost of GBX 234 ($3.03) per share, for a total transaction of £999,147.24 ($1,291,722.35). Insiders purchased 1,391,473 shares of company stock valued at $103,604,725 over the last three months. 14.02% of the stock is owned by corporate insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.